Progress in survival outcomes in patients with advanced ovarian cancer treated by neo-adjuvant platinum/taxane-based chemotherapy and late interval debulking surgery.

MLA

Stoeckle, Eberhard, et al. “Progress in Survival Outcomes in Patients with Advanced Ovarian Cancer Treated by Neo-Adjuvant Platinum/Taxane-Based Chemotherapy and Late Interval Debulking Surgery.” Annals of Surgical Oncology, vol. 21, no. 2, Feb. 2014, pp. 629–36. EBSCOhost, https://doi.org/10.1245/s10434-013-3278-x.

APA

Stoeckle, E., Bourdarias, L., Guyon, F., Croce, S., Brouste, V., Thomas, L., & Floquet, A. (2014). Progress in survival outcomes in patients with advanced ovarian cancer treated by neo-adjuvant platinum/taxane-based chemotherapy and late interval debulking surgery. Annals of Surgical Oncology, 21(2), 629–636. https://doi.org/10.1245/s10434-013-3278-x

Chicago

Stoeckle, Eberhard, Lionnel Bourdarias, Frédéric Guyon, Sabrina Croce, Véronique Brouste, Laurence Thomas, and Anne Floquet. 2014. “Progress in Survival Outcomes in Patients with Advanced Ovarian Cancer Treated by Neo-Adjuvant Platinum/Taxane-Based Chemotherapy and Late Interval Debulking Surgery.” Annals of Surgical Oncology 21 (2): 629–36. doi:10.1245/s10434-013-3278-x.